Long-acting parathyroid hormone receptor agonist rectifies hypocalcemia in autosomal dominant hypocalcemia type 1 mice.

Hannan FM., Stevenson M., Elajnaf T., Rostom H., Lines KE., Stewart M., Wells S., Moir L., Gardella TJ., Thakker RV.

Eneboparatide, a long-acting modified form of parathyroid hormone, increases serum calcium levels without increasing urine calcium in mice with autosomal dominant hypocalcemia type 1.

DOI

10.1172/JCI201759

Type

Journal article

Publication Date

2026-04-01T00:00:00+00:00

Volume

136

Keywords

Bone biology, Calcium, Endocrinology, Animals, Hypocalcemia, Mice, Calcium, Hypoparathyroidism, Parathyroid Hormone-Related Protein, Parathyroid Hormone, Receptor, Parathyroid Hormone, Type 1, Male, Hypercalciuria

Permalink More information Close